行情

CBLI

CBLI

克利夫兰生物实验室
NASDAQ

实时行情|Nasdaq Last Sale

1.790
+0.100
+5.92%
盘后: 1.800 +0.01 +0.56% 19:49 03/27 EDT
开盘
1.850
昨收
1.690
最高
1.915
最低
1.710
成交量
34.00万
成交额
--
52周最高
5.00
52周最低
0.5000
市值
2,022.38万
市盈率(TTM)
-8.5279
分时
5日
1月
3月
1年
5年

EPS

CBLI 新闻

更多
  • INO, MNK among premarket gainers
  • Seeking Alpha - Article · 03/12 13:16
  • Familiar names up premarket as COVID-19 weighs on market
  • Seeking Alpha - Article · 03/12 10:39
  • 90 Biggest Movers From Yesterday
  • Benzinga · 03/12 10:10
  • 78 Stocks Moving In Wednesday's Mid-Day Session
  • Benzinga · 03/11 16:12

所属板块

生物技术和医学研究
-2.44%
制药与医学研究
-0.87%

热门股票

代码
价格
涨跌幅

CBLI 简况

Cleveland BioLabs, Inc. (CBLI) is a biopharmaceutical company. The Company is engaged in developing approaches to activate the immune system and address serious medical needs. Its platform of Toll-like immune receptor activators has applications in mitigation of radiation injury and immuno-oncology. Its advanced product candidate is Entolimod, an immuno-stimulatory agent, which it is developing as a radiation countermeasure and an immunotherapy for oncology and other indications. Its other products include CBLB612, Mobilan and CBL0137. CBLB612 is a compound based upon a natural activator of another tissue-specific component of the innate immune system, the toll-like receptor 2 (TLR2)/ toll-like receptor 6 (TLR6) heterodimeric receptor. Mobilan is a recombinant non-replicating adenovirus that directs expression of TLR5 and its agonistic ligand. CBL0137 is a small molecule with a multi-targeted mechanism of action that may be useful for the treatment of various types of cancer.
展开

微牛提供Cleveland BioLabs, Inc.(NASDAQ-CBLI)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的CBLI股票新闻,以帮助您做出投资决策。